Table of contents
3. Viscosizer TD:Protein Stability Characterization Platform
00:05
7. Emerging Market - Towards novel biologics
00:34
8. Emerging Market - Towards novel biologics
00:44
12. Protein stability profiling
00:12
13. Protein stability profiling
00:26
14. Viscosizer TD – Physical stability profiling
00:22
15. Viscosizer TD – Physical stability profiling
00:18
16. Viscosizer TD – Physical stability profiling
00:10
18. Viscosizer TD – Instrument
00:16
19. Viscosizer TD – Instrument
00:33
20. Viscosizer TD – Instrument
00:27
21. Viscosizer TD – Instrument
00:28
22. Viscosizer TD – Instrument
00:13
23. Taylor Dispersion Analysis – Size
00:20
24. Taylor Dispersion Analysis – Size
00:50
25. Taylor Dispersion Analysis – Size
00:27
30. Taylor Dispersion Analysis – kD
01:28
33. Poiseuille Flow – Viscosity
00:15
34. Poiseuille Flow – Viscosity
00:14
35. Poiseuille Flow – Viscosity
00:03
36. Poiseuille Flow – Viscosity
00:02
37. Poiseuille Flow – Viscosity
00:04
38. Poiseuille Flow – Viscosity
00:14
39. Poiseuille Flow – Viscosity
00:05
41. Measurement Capabilities
00:14
42. Measurement Capabilities
00:05
43. Measurement Capabilities
00:19
45. Applications: Early developability screen of mAb candidates using TDA
00:41
46. Applications: Early developability screen of mAb candidates using TDA
00:20
47. Applications: Early developability screen of mAb candidates using TDA
00:18
48. Applications: Early developability screen of mAb candidates using TDA
00:34
49. Applications: Early developability screen of mAb candidates using TDA
00:05
50. Applications: Early developability screen of mAb candidates using TDA
00:05
51. Applications: DLS vs. TDA for characterisation of peptide and protein aggregates
00:15
52. Applications: DLS vs. TDA for characterisation of peptide and protein aggregates
00:38
53. Applications: DLS vs. TDA for characterisation of peptide and protein aggregates
00:47
54. Applications: DLS vs. TDA for characterisation of peptide and protein aggregates
00:05
55. Applications: Peptide- peptide interaction analysis using TDA
00:55
56. Applications: Peptide- peptide interaction analysis using TDA
00:08
57. Applications: Aggregation of cyclodextrin-drug conjugate using TDA analysis
00:33
60. Thank you for your attentionAny questions?
07:30